Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Catalyst Bio
(NQ:
CBIO
)
6.530
USD
-0.110 (-1.66%)
Official Closing Price
Updated: 5:21 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
332,000
Open
6.670
Bid (Size)
6.250 (89)
Ask (Size)
6.900 (5)
Prev. Close
6.640
Today's Range
6.310 - 6.745
52wk Range
3.430 - 8.940
Shares Outstanding
11,935,169
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital
January 15, 2021
From
GlobeNewswire News Releases
Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd Annual American Society of Hematology Conference
December 07, 2020
From
GlobeNewswire News Releases
Performance
YTD
+6.01%
+6.01%
1 Month
-5.50%
-5.50%
3 Month
+1.95%
+1.95%
6 Month
+9.56%
+9.56%
1 Year
-10.79%
-10.79%
More News
Read More
Catalyst Biosciences Hosting Research & Development Call on Systemic Complement Regulator Programs
December 03, 2020
From
GlobeNewswire News Releases
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Hemophilia A or B with Inhibitors
December 02, 2020
From
GlobeNewswire News Releases
Catalyst Biosciences to Present at 32nd Annual Piper Sandler Virtual Healthcare Conference
November 24, 2020
From
GlobeNewswire News Releases
Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference
November 05, 2020
From
GlobeNewswire News Releases
Catalyst Biosciences Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate Update
November 05, 2020
From
GlobeNewswire News Releases
Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference
November 03, 2020
From
GlobeNewswire News Releases
Catalyst Biosciences Receives US Patent for its Anti-Complement Factor 3 Portfolio of Engineered Proteases
October 14, 2020
From
GlobeNewswire News Releases
Catalyst Biosciences to Present at the Stifel Immunology and Inflammation Summit
September 25, 2020
From
GlobeNewswire News Releases
Catalyst Biosciences to Participate in Two Upcoming Investor Conferences
September 10, 2020
From
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.